Adisseo(SH:600299)2025-10-30 10:55Financial Performance - The company's operating revenue for Q3 2025 was CNY 4,418,974,908, representing a year-on-year increase of 7.39%[3] - The total profit for the period was CNY 354,353,219, a decrease of 30.89% compared to the same period last year[3] - The net profit attributable to shareholders was CNY 250,201,793, down 36.77% year-on-year[3] - The basic earnings per share for the period was CNY 0.09, reflecting a decrease of 40.00% compared to the previous year[3] - Total operating revenue for the first three quarters of 2025 reached CNY 12,931,042,871, an increase of 13.6% compared to CNY 11,375,947,704 in the same period of 2024[17] - Operating profit for the first three quarters of 2025 was CNY 1,375,934,261, slightly down from CNY 1,378,171,752 in 2024, indicating a stable performance[18] - Net profit attributable to shareholders of the parent company for the first three quarters of 2025 was CNY 990,385,122, compared to CNY 1,003,279,525 in 2024, reflecting a decrease of 1.3%[18] - The company reported a comprehensive income total of CNY 1,857,785,945 for the first three quarters of 2025, significantly up from CNY 950,427,428 in 2024[19] Assets and Liabilities - Total assets at the end of the period amounted to CNY 25,174,272,502, an increase of 13.11% compared to the end of the previous year[4] - As of September 30, 2025, the total assets of the company reached RMB 25,174,272,502, an increase from RMB 22,257,398,577 as of December 31, 2024, representing a growth of approximately 8.6%[13] - The company's current assets totaled RMB 7,319,268,891, up from RMB 6,395,939,923, indicating an increase of about 14.4% year-over-year[14] - Total liabilities increased to RMB 8,229,869,392 from RMB 6,687,616,587, representing a growth of about 23%[15] - The company's long-term borrowings rose significantly to RMB 1,889,718,377 from RMB 925,558,489, indicating an increase of approximately 104%[15] - The non-current assets totaled RMB 17,855,003,611, up from RMB 15,861,458,654, reflecting an increase of about 12.5%[14] - The company's equity remained stable at RMB 2,681,901,273, unchanged from the previous period[15] Cash Flow - The company reported a net cash flow from operating activities of CNY 2,284,431,324 for the year-to-date, showing a 2.86% increase[3] - Cash flow from operating activities for the first three quarters of 2025 was CNY 2,284,431,324, slightly higher than CNY 2,220,971,908 in 2024[22] - The company incurred a net cash outflow from investing activities of CNY 2,069,867,110 in the first three quarters of 2025, compared to CNY 1,177,816,244 in 2024, indicating increased investment activities[22] - Cash inflow from financing activities in the first three quarters of 2025 was CNY 946,425,940, a significant increase from CNY 266,097,772 in 2024[22] - Net cash flow from financing activities was $215,369,677, a significant improvement compared to a net outflow of $(722,744,647) in the previous period[23] - Total cash and cash equivalents at the end of the period reached $1,759,751,219, up from $1,334,456,897 year-over-year[23] - The net increase in cash and cash equivalents was $526,115,384, compared to $329,229,338 in the prior year[23] - Cash outflows from financing activities totaled $731,056,263, down from $988,842,419 in the previous period[23] - The impact of exchange rate changes on cash and cash equivalents was $96,181,493, compared to $8,818,321 in the prior year[23] Market Conditions and Strategy - The company plans to continue investing in business growth and R&D innovation despite facing a challenging market environment[8] - The increase in revenue was primarily driven by the rising penetration of liquid methionine and double-digit sales growth in specialty products[8] - The company experienced adverse impacts from rising raw material prices, tariff policies, and a sharp decline in vitamin product prices[8] Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 282,051,876, a decrease from CNY 300,385,838 in 2024, suggesting a potential shift in focus[17] Other Financial Metrics - The weighted average return on net assets was 1.48%, a decrease of 3.29 percentage points from the previous year[4] - The cash and cash equivalents increased to RMB 1,759,751,219 from RMB 1,265,778,795, reflecting a growth of approximately 39%[13] - Accounts receivable rose to RMB 2,093,738,151, compared to RMB 1,969,896,420, marking an increase of about 6.3%[14] - Inventory levels increased to RMB 2,476,884,888 from RMB 2,428,174,242, which is an increase of approximately 2%[14] - The company reported a significant increase in other receivables, which rose to RMB 167,468,982 from RMB 90,753,937, marking an increase of approximately 84.5%[14] - The total equity attributable to shareholders of the parent company rose to CNY 16,912,994,342 in 2025, up from CNY 15,542,390,570 in 2024, indicating improved shareholder value[16]